Skip to main content
. 2013 Dec 5;106(1):djt341. doi: 10.1093/jnci/djt341

Table 1.

Characteristics obtained at the first breast density measurement for each woman by Breast Imaging Reporting and Data System (BI-RADS; mammographic breast density category) in the Breast Cancer Surveillance Consortium, 1995 to 2009

Characteristic Breast density
Total BI-RADS 1, almost entirely fatty BI-RADS 2, scattered fibroglandular densities BI-RADS 3, heterogenously dense BI-RADS 4, extremely dense
(n = 724603) % (n = 69150) % (n = 306089) % (n = 276710) % (n = 72654) %
Age, y
 40–49 46.8 26.7 38.0 55.5 69.1
 50–59 27.7 28.2 30.1 26.7 21.5
 60–69 15.8 26.0 19.5 11.6 6.4
 70–79 9.7 19.1 12.4 6.1 3.1
Race/ethnicity
 White, non-Hispanic 73.4 70.7 74.3 73.3 72.4
 Black, non-Hispanic 2.3 3.4 2.4 2.1 1.6
 Asian 7.6 4.0 5.3 9.2 14.1
 Hispanic 13.6 17.2 14.6 12.8 9.5
 Other/mixed 3.1 4.7 3.4 2.7 2.3
 Missing* (6.7) (9.1) (7.0) (6.1) (5.6)
Body mass index, kg/m2
 <18.5 1.8 0.6 1.0 2.0 5.8
 18.5 to <25 46.5 20.8 37.3 55.7 72.6
 25 to <30 28.9 30.4 32.8 27.5 16.3
30 22.8 48.2 28.9 14.8 5.2
 Missing* (16.4) (17.7) (17.4) (15.7) (13.9)
Parity status
 Parous 82.6 86.6 86.1 80.4 72.4
 Nulliparous 17.4 13.4 13.9 19.6 27.6
 Missing* (13.1) (14.6) (13.7) (12.1) (12.7)
Menopausal status
 Premenopausal 45.8 23.1 36.4 55.7 70.2
 Postmenopausal 54.2 76.9 63.6 44.3 29.8
 Missing* (14.6) (12.9) (14.2) (15.6) (14.6)
Oral contraceptive use†
 Yes 2.9 1.3 2.1 3.8 4.7
 No 51.4 52.4 48.3 53.7 54.6
 Missing‡ 45.7 46.3 49.6 42.5 40.7
Hormone therapy use†
 Yes 18.6 17.4 19.8 18.5 14.5
 No 81.4 82.6 80.2 81.5 85.5
 Missing* (9.3) (8.4) (9.4) (9.6) (8.7)
Prior diagnosis of breast cancer
 Yes 3.4 3.7 3.9 3.1 2.5
 No 96.6 96.3 96.1 96.9 97.5
 Missing* (6.7) (6.8) (7.4) (5.9) (6.7)
First-degree family history of breast or ovarian cancer
 Yes 13.6 13.0 13.4 13.8 13.9
 No 86.4 87.0 86.6 86.2 86.1
 Missing* (4.5) (4.9) (4.1) (4.8) (4.6)

* Percentage of total.

† At time of mammogram.

‡ Retained in analysis.